Nordson Q1 Earnings Call Highlights

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

• Nordson is positioned across the semiconductor supply chain both technologically and geographically

  80% confidence

• Winter storms at the end of January temporarily impacted production and certain medical supply chain activity, estimated at about 1% sales impact

  80% confidence

• Backlog entering Q2 was up approximately 4% year-over-year with broad-based order momentum and strength in ATS

  80% confidence

• The high end of full-year sales range assumes continued momentum from electronics end markets and modest improvement in industrial and automotive product lines

  80% confidence

• Without the late-quarter storm-related disruption, medical organic performance would have been about 4%

  80% confidence

• There is no fundamental change in the margin outlook and approximately 40% incremental margins are a normal ongoing expectation

  80% confidence

• AMI (acoustic/optical inspection) followed two really strong years of growth and is expected to grow again this year

  80% confidence

• The low end of guidance assumes a broader pullback in demand in the second half, which the company does not currently see but views as prudent to plan for

  80% confidence

• Organic growth was driven by robust demand in Asia across most of our end markets

  80% confidence

• X-ray test and inspection systems are beginning to inflect after being down last year

  80% confidence

• Semiconductor applications represent approximately 50% of ATS revenue

  80% confidence

• The company entered fiscal 2026 optimistic about end market demand trends

  80% confidence

• Quality control needs are expanding opportunities for test and inspection in semiconductor advanced packaging

  80% confidence